Stock Details
TEVA is Teva Pharmaceutical Industries Limited's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 9.79$. Average daily volumn in 3 months 8.52M. Market cap 9.84B



Stock symbol : TEVA. Exchange : NYSE. Currency : USD
Lastest price : 8.92$. Total volume : 17.22M. Market state PRE
Click reload if you want to check the lastest price on market!!!

Teva Pharmaceutical Industries Limited (TEVA)
Last Price
8.92$
Change
-0.02
Volume
17.22M

Previous Close8.94
Open8.93
Day Range8.64-8.94
Bid0.00 x 21.5k
Ask0.00 x 1.2k
Volume17.22M
Average Volume8.52M
Market Cap9.84B
Beta1.47
52 Week Range8.24-13.30
Trailing P/EN/A
Foward P/E3.46
Dividend (Yield %)N/A
Ex-Dividend Date2017-11-27



Financial Details


According to Teva Pharmaceutical Industries Limited's financial reports the company's revenue in 2020 were 16.66B an decrease(0%) over the years 2019 revenue that were of 16.89B. In 2020 the company's total earnings were -3.99B while total earnings in 2019 were -999M( +200.3%).


Loading ...



Organization

Teva Pharmaceutical Industries Ltd., also known as Teva Pharmaceuticals, is a global pharmaceutical company with headquarters in Petah Tikva, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals. In 2020, Teva Pharmaceuticals was the second largest generic drug manufacturer and the eighteenth largest pharmaceutical company in the world.

Teva Pharmaceutical Industries Limited_logo

Market Cap:
9.84B
Revenue:
16.66B
Total Assets:
50.64B
Total Cash:
2.18B


News about "Teva Pharmaceutical Industries Limited"

Teva Pharmaceutical Industries Limited Q2 adjusted earnings Inline With Estimates_image

Teva Pharmaceutical Industries Limited Q2 adjusted earnings Inline With Estimates

Teva Pharmaceutical Industries Limited (TEVA) released earnings for its second quarter that climbed from last year. The company's earnings came in at $207 million, or $0.19 per share. This compares ...

Source from : Nasdaq - 7 hours ago


Teva Pharmaceutical Industries Limited’s (NYSE: TEVA) -2.13% Decline Frightens Investors Off The Stock

Teva Pharmaceutical Industries Limited (NYSE:TEVA) traded at $8.75 at last check on Tuesday, July 27, made a downward move of -2.13% on its previous day’s price. Looking at the stock we see that its ...

Source from : stocksregister - 1 days ago


Teva Pharmaceutical Industries Limited [TEVA] moved down -1.01: Why It’s Important

TEVA] closed the trading session at $8.81 on 07/23/21. The day’s price range saw the stock hit a low of $8.77, while the highest price level was $8.93. The company report on July 21, 2021 that Teva ...

Source from : dbtnews - 2 days ago


Reason’s why Teva Pharmaceutical Industries Limited (TEVA) is an asset to your trade with current Target Price of $11.92_image

Reason’s why Teva Pharmaceutical Industries Limited (TEVA) is an asset to your trade with current Target Price of $11.92

For the readers interested in the stock health of Teva Pharmaceutical Industries Limited (TEVA). It is currently valued at $8.38. When the transactions were called off in the previous session, Stock ...

Source from : investchronicle - 21 days ago


Market Analysts see Teva Pharmaceutical Industries Limited [TEVA] falling to $11. Time to buy?_image

Market Analysts see Teva Pharmaceutical Industries Limited [TEVA] falling to $11. Time to buy?

TEVA] closed the trading session at $8.78 on 07/20/21. The day’s price range saw the stock hit a low of $8.395, while the highest price level was $8.795. The company report on July 1, 2021 that Teva t ...

Source from : dbtnews - 1 month ago


Teva Pharmaceutical Industries Limited’s Stock Loss -2.67%, But It May Still Be Worth Investing In.

The trading price of Teva Pharmaceutical Industries Limited (NYSE:TEVA) closed lower on Monday, July 19, closing at $8.38, -2.67% lower than its previous close. >> 7 Top Picks for the Post-Pandemic Ec ...

Source from : stocksregister - 8 days ago


Teva Pharmaceutical Industries Limited: Reaffirming BUY ahead of 2Q results

Find the latest Teva Pharmaceutical Industries (TEVA) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance ...

Source from : YAHOO!Finance - 2 days ago


Teva Pharmaceutical Industries Limited (NYSE: TEVA)’s 0.78% Gain This Week Just Tells Us Something New_image

Teva Pharmaceutical Industries Limited (NYSE: TEVA)’s 0.78% Gain This Week Just Tells Us Something New

During the recent session, Teva Pharmaceutical Industries Limited (NYSE:TEVA)’s traded shares were 2.76 million, with the beta value of the company hitting 1.45. At the last check today, the stock’s ...

Source from : marketingsentinel - 6 days ago


Teva Pharmaceutical Industries Ltd (TEVA): Price Now Near $8.38; Daily Chart Shows Downtrend on 50 Day Basis_image

Teva Pharmaceutical Industries Ltd (TEVA): Price Now Near $8.38; Daily Chart Shows Downtrend on 50 Day Basis

TEVA ranks 199th in terms of today’s price percentage change out of Pharmaceutical Products stocks. At the time of this writing, TEVA’s price is down $-0.22 (-2.56%) from the day prior. TEVA has seen ...

Source from : ETF Daily News - 9 days ago


Teva Pharmaceutical Industries Limited (NYSE: TEVA) Down Almost -19.10% In One Month, Long Term Looking Good

Teva Pharmaceutical Industries Limited (NYSE:TEVA)’s traded shares stood at 3.55 million during the latest session, with the company’s beta value hitting 1.46. At the last check today, the stock’s ...

Source from : marketingsentinel - 13 days ago


Highlights from the Ratings and Financial Report for Teva Pharmaceutical Industries Limited (TEVA)

Teva Pharmaceutical Industries Limited (NYSE:TEVA) went down by -1.82% from its latest closing price compared to the recent 1-year high of $13.30. The company’s stock price has collected -7.42% of ...

Source from : newsheater - 2 month ago


Is Teva Pharmaceutical Industries (NYSE:TEVA) Using Too Much Debt?

We note that Teva Pharmaceutical Industries Limited (NYSE:TEVA) does have debt on its balance sheet. But the real question is whether this debt is making the company risky. Generally speaking ...

Source from : Nasdaq - 1 month ago


Teva Pharmaceutical Industries Ltd.

Vergis Independent Director Dentsply Sirona, Inc., Teva Pharmaceutical Industries Ltd., Dentsply Sirona France SAS, Church & Dwight Co., Inc., IMPAX Corp Amir Elstein Director TowerJazz Japan Ltd ...

Source from : Wall Street Journal - 21 days ago


Becker’s Nevus Market May See Big Move 2026: Boehringer Ingelheim, Eisai Inc., Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd.

Global Becker’s Nevus Market report has covered and analyzed the potential of Worldwide market Industry and provides statistics and information on market dynamics, market analysis, growth factors, key ...

Source from : manometcurrent.com - 12 days ago


Desmopressin Acetate Market May See Big Move 2027: Ferring Pharmaceuticals Inc., American Regent Inc., Sun Pharmaceutical Industries Ltd

Top Key Players Included in This Report: Ferring Pharmaceuticals Inc., American Regent Inc., Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd., Apotex Inc., Glenmark ...

Source from : manometcurrent.com - 6 days ago


Specialty Generic Drugs Market to Set Phenomenal Growth by 2026 | Mallinckrodt, Apotex, Teva Pharmaceuticals USA

To understand big picture lot of industry players were analysed and some of them are Sun Pharmaceutical Industries Ltd., Mylan N.V., Pfizer Inc., Mallinckrodt, Apotex Corp., Teva Pharmaceuticals ...

Source from : MarketWatch - 21 days ago


Menstrual Cramps Treatment Market Growth Rate And Recent Trends By Top Vendors: Pfizer, Teva Pharmaceuticals USA, Color Seven Co., Ltd

A recent research report on Global Menstrual Cramps Treatment Market Industry Analysis and Opportunity Assessment 2021-2028 by Data Bridge Market Research comprises of productive information of the ...

Source from : PharmiWeb - 21 days ago


Teva Pharmaceutical Industries Ltd.

TEVA PHARMACEUTICALS's gross profit margin for the first quarter of its fiscal year 2021 is essentially unchanged when compared to the same period a year ago. Even though sales decreased ...

Source from : TheStreet.com - 16 days ago


Teva Pharmaceutical Industries Ltd. ADR

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Source from : Barron's - 19 days ago


Teva Pharmaceutical Industries Ltd ADR TEVA

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Source from : Morningstar%2c Inc. - 14 days ago


Teva Pharmaceutical Industries Ltd

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company headquartered in Petah Tikva, Israel. It specializes primarily in generic drugs, but other business interests ...

Source from : Newsweek - 1 month ago


Teva Pharmaceutical Industries Ltd. (TEVA) Moves 7.5% Higher: Will This Strength Last?

Teva Pharmaceutical Industries Ltd. (TEVA) shares ended the last trading session 7.5% higher at $11.53. The jump came on an impressive volume with a higher-than-average number of shares changing ...

Source from : MSN - 1 month ago


Teva Pharmaceutical Industries Ltd. ADR

No news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the ...

Source from : Wall Street Journal - 1 month ago


Teva Pharmaceutical Industries Ltd.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Source from : Barron's - 1 month ago


Teva Pharmaceutical Industries Ltd.

Below is a summary of the major fundamental and technical factors we consider when determining our overall recommendation of TEVA shares. It is provided in order to give you a deeper understanding ...

Source from : TheStreet.com - 1 month ago


Teva Pharmaceutical Industries Ltd.

You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

Source from : Law360 - 1 month ago


Teva Pharmaceutical Industries Ltd (ADR)

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment ...

Source from : Reuters - 11 month ago


Teva Pharmaceutical Industries Limited (TEVA) Just Got Our Attention

Teva Pharmaceutical Industries Limited (NYSE:TEVA) went down by -1.01% from its latest closing price compared to the recent 1-year high of $13.30. The company’s stock price has collected 2.32% of ...

Source from : newsheater - 8 month ago


Teva- Pharmaceutical Industries Ltd. - ADR

Teva Pharmaceutical Industries Ltd., an Israeli-based company, is one of the world's largest producers of generic medications. In addition to its generic tablets, capsules, ointments, creams ...

Source from : U.S. News & World Report - 11 month ago


Teva Pharmaceutical Industries Limited (TEVA)

TEL AVIV, Israel & PARSIPPANY, N.J., July 21, 2021--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced changes to its leadership team. Brendan O’Grady, Executive Vice President, ...

Source from : Yahoo Finance - 11 month ago


Teva Pharmaceutical’s U.S. unit indicted on price-fixing charges

WASHINGTON—The U.S. business of Teva Pharmaceutical Industries Ltd. has been indicted on charges the drugmaker fixed prices on generic drugs, according to a person familiar with the matter.

Source from : Fox Business - 11 month ago


Teva Pharmaceutical Industries Limited (TEVAN.MX)

In this episode of Influencers, Eli Lilly Chairman & CEO David Ricks joins Andy to discuss the latest in the pharmaceutical industry, new progress in the fight against COVID-19, and potential ...

Source from : Yahoo Finance - 3 month ago


Teva rejigs top management_image

Teva rejigs top management

The senior management of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) is undergoing a shakeup. Brendan O’Grady, Executive Vice President, North America Commercial, is leaving the ...

Source from : globes.co.il - 6 days ago


Future Developments We’ll See in Contract Pharmaceutical Manufacturing Market In Various Activities like Design Conception To Commercialization_image

Future Developments We’ll See in Contract Pharmaceutical Manufacturing Market In Various Activities like Design Conception To Commercialization

The global contract pharmaceutical manufacturing market growth is dependent on the introduction of new technologies in the pharmaceutical industry The subject of discussion in this report examines the ...

Source from : openpr.com - 9 hours ago


Antares Pharma Announces FDA Acceptance of IND Application for ATRS-1902 for Adrenal Crisis Rescue

Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug ...

Source from : Associated Press - 6 days ago


Is TEVA A Good Stock To Buy?_image

Is TEVA A Good Stock To Buy?

In this article you are going to find out whether hedge funds think Teva Pharmaceutical Industries Limited (NYSE:TEVA) is a good investment right now. We like to check what the smart money thinks ...

Source from : YAHOO!Finance - 8 days ago


The Globe and Mail

Teva Pharmaceutical Industries Ltd. (NYSEandTASE:TEVA) today presented new epidemiology data on migraine from the State of Israel which indicate that socio-economic factors may contribute to ...

Source from : The Globe and Mail - 1 month ago


Teva and Bioeq Announce Commercial Partnership for Biosimilar

TEL AVIV, Israel & ZURICH--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: and TASE: TEVA) and Bioeq AG ("Bioeq") today announced that they have entered into a strategic partnership ...

Source from : Business Wire - 1 month ago


The Globe and Mail

Teva Pharmaceutical Industries Ltd. (NYSE: and TASE: TEVA) and Bioeq AG ("Bioeq") today announced that they have entered into a strategic partnership for the exclusive commercialization of Bioeq's ...

Source from : The Globe and Mail - 1 month ago


EC Investigating Teva for Allegedly Delaying, Disparaging Competing MS Drug

The European Commission has opened a formal antitrust investigation to assess whether the pharmaceutical company Teva Pharmaceutical Industries Ltd. has illegally delayed the market entry and ...

Source from : The National Law Review - 1 month ago


Teva to Host Conference Call to Discuss Second Quarter 2021 Financial Results at 8 a.m. ET on July 28, 2021

TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its financial results for the second quarter of ...

Source from : Business Wire - 27 days ago


Teva Announces the U.S. Launch of its Generic Version of SOOLANTRA® (ivermectin) Cream, 1% for Once Daily Treatment of Rosacea

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd.(NYSE and TASE: TEVA), today announced the U.S. launch of its generic version of once daily SOOLANTRA® (ivermectin ...

Source from : Benzinga.com - 1 month ago


Ex-FDA commissioner: Pharmaceutical companies promoted opioids as safe and effective_image

Ex-FDA commissioner: Pharmaceutical companies promoted opioids as safe and effective

Pharmaceutical companies hoping to increase the sale of opioids began promoting the drugs as safe and effective for migraine headaches, back pain and other chronic conditions during the 1990s, even th ...

Source from : Newsday - 11 days ago


Teva, Bioeq Reach Deal To Commercialize Biosimilar Candidate Of Ophthalmology Drug Ranibizumab

Disclaimer | Accessibility Statement | Commerce Policy | Made In NYC | Stock quotes by finanzen.net (RTTNews) - Teva Pharmaceutical Industries Ltd. (TEVA) said that it reached a strategic ...

Source from : Business Insider - 1 month ago


Teva and Bioeq Announce Commercial Partnership for Biosimilar

TEL AVIV, Israel & ZURICH, June 28, 2021--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: and TASE: TEVA) and Bioeq AG ("Bioeq") today announced that they have entered into a strategic ...

Source from : Yahoo Finance - 29 days ago